MedPath

四川奇裕医药科技有限公司

Ownership
-
Established
2021-04-29
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Desmopressin Injection

Product Name
注射用醋酸去氨加压素
Approval Number
国药准字H20254241
Approval Date
May 27, 2025
NMPA

Desmopressin Injection

Product Name
注射用醋酸去氨加压素
Approval Number
国药准字H20254242
Approval Date
May 27, 2025
NMPA

Terbutaline Sulfate Nebuliser Solution

Product Name
硫酸特布他林雾化吸入用溶液
Approval Number
国药准字H20234747
Approval Date
Dec 29, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.